ERCC2 rs50871: What Your Genotype Means
The rs50871 variant is a single nucleotide polymorphism located within the ERCC2 gene. Research suggests this variant may interact with other genetic markers to influence survival outcomes in older populations and prognosis in certain cancer types.
What each genotype means
Potential longevity and cancer risk
Research suggests this genotype may interact with other genetic markers, such as those in the FOXO3 or TP53 genes, to influence survival outcomes in older age. In some studies of specific cancer types, this genotype has been associated with different survival outcomes compared to other variants, though these findings vary significantly by population and disease context.
This is a common genotype found in many global populations, though exact frequencies vary by ancestry.
Potential longevity and cancer risk
This genotype represents a heterozygous state for the ERCC2 variant. Studies indicate that individuals with this profile may show different survival patterns in the context of specific health conditions or aging when compared to those with homozygous genotypes, reflecting the complex role of DNA repair pathways in long-term health.
This is a common genotype found in many global populations, though exact frequencies vary by ancestry.
Potential longevity and cancer risk
This genotype is associated with the ERCC2 gene, which is involved in DNA repair mechanisms. Research indicates that this variant may interact with other genes to influence late-life survival, though the specific impact can differ depending on an individual's overall genetic background and environmental factors.
This is a common genotype found in many global populations, though exact frequencies vary by ancestry.
Understanding the rs50871 Variant
The rs50871 variant is a specific genetic change, or single nucleotide polymorphism (SNP), located within the ERCC2 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. The ERCC2 gene provides instructions for making a protein that is essential for the nucleotide excision repair (NER) pathway. This biological system is responsible for identifying and correcting damaged DNA, such as damage caused by ultraviolet light or other environmental stressors. Because the NER pathway is critical for maintaining genomic stability, variations in genes like ERCC2 are frequently studied to understand how they might influence cellular health, aging, and the body's response to DNA damage over a lifetime.
The Role of ERCC2 in DNA Repair
The ERCC2 gene, also known as XPD, encodes a protein that functions as a helicase—an enzyme that unwinds DNA. This unwinding is a necessary step for the NER pathway to access and repair damaged segments of the genetic code. When this repair mechanism is efficient, cells can effectively manage mutations and prevent the accumulation of genetic errors. However, if the function of the ERCC2 protein is altered by genetic variants, the efficiency of this repair process may change. Scientists investigate these variants to see if they correlate with differences in how individuals process DNA damage, which in turn may influence susceptibility to certain diseases or affect how the body responds to medical treatments that target rapidly dividing cells.
Research on Longevity and Cancer Prognosis
Scientific studies have explored the potential impact of rs50871 on health outcomes, though the evidence remains complex and context-dependent. Some research has identified an interaction between ERCC2 rs50871 and FOXO3 rs2802292, suggesting a potential influence on survival in individuals over the age of 85. Other studies have examined the variant in the context of cancer prognosis, particularly in gastric and melanoma patients, where certain genotypes have been associated with varying survival rates. It is important to note that these findings are often based on specific populations and have not always been replicated across all ethnic groups. Furthermore, many of these studies are observational, meaning they identify statistical correlations rather than direct cause-and-effect relationships. Consequently, the clinical significance of this variant is considered moderate, and it is not currently used as a standard diagnostic tool.
Population Frequency and Interpretation
The rs50871 variant is considered a common SNP, meaning it is found frequently across diverse human populations. Because it is common, most individuals will carry at least one copy of the variant. When interpreting genetic data, it is crucial to understand that having a specific genotype does not determine a health outcome. Genetic associations are influenced by a wide array of factors, including lifestyle, environment, and the presence of other genetic variants. Because the evidence linking rs50871 to specific health outcomes is mixed and often limited to specific cohorts, this information should be viewed as a piece of a much larger, complex biological puzzle rather than a definitive health prediction.
What You Can Do With This Information
If you have received information about your rs50871 genotype, it is important to maintain a balanced perspective. This variant is a subject of ongoing scientific research, not a clinical diagnostic marker. You cannot use this information to predict your personal longevity or your risk of developing specific diseases. If you are concerned about your health, family history, or the results of a genetic test, the best course of action is to consult with a qualified healthcare provider or a genetic counselor. They can help you interpret your results within the context of your overall health profile. Never make changes to your medical care, diet, or lifestyle based solely on a single genetic variant report without professional medical guidance.
How common is this variant?
The rs50871 variant is common across global populations, with varying frequencies of the G and T alleles observed across different ancestral groups.
Frequently asked questions
Is rs50871 a diagnostic test for cancer?
No, rs50871 is not a diagnostic test for cancer. It is a genetic variant that researchers study to understand potential associations with disease prognosis, but it cannot be used to diagnose or predict the development of cancer.
Does my genotype mean I will live longer?
No. While some studies have explored interactions between rs50871 and other genes in relation to longevity, these findings are statistical associations in specific groups. Your genotype does not determine your lifespan.
Should I change my lifestyle based on this variant?
You should not change your lifestyle based on this variant. Health decisions should be based on established medical advice, such as maintaining a healthy diet and regular exercise, rather than individual genetic markers.
Where can I find more information about my specific results?
If you have questions about your genetic results, you should speak with a healthcare provider or a certified genetic counselor. They are trained to help you understand what genetic information means for your personal health.
Sources & further reading
Educational information only, last refreshed 10/30/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs50871?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ERCC2
XPD (Asp312Asn) nucleotide excision repair variant influencing cellular capacity to clear UV-induced cyclobutane pyrimidine dimers and mitigate actinic elastosis.
This polymorphism in the ERCC2 gene is associated with variations in DNA repair capacity and has been linked to altered cancer risk profiles in meta-analyses.